Literature DB >> 23636255

Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.

Beth E Fisher1, Quanzheng Li, Angelo Nacca, George J Salem, Jooeun Song, Jeanine Yip, Jennifer S Hui, Michael W Jakowec, Giselle M Petzinger.   

Abstract

We have previously demonstrated changes in dopaminergic neurotransmission after intensive exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson's disease (PD), including an increase in the dopamine D2 receptor (DA-D2R), using noninvasive PET imaging with the radioligand [18F]fallypride. The purpose of this feasibility and translational study was to examine whether intensive exercise leads to similar alterations in DA-D2R expression using PET imaging with [18F]fallypride in individuals with early-stage PD. In this pilot study, four patients with early-stage PD were randomized to receive intensive exercise (treadmill training sessions three times/week for 8 weeks) or no exercise. Two healthy age-matched individuals participated in treadmill training. Alterations in the DA-D2R binding potential (BP) as a marker for receptor expression were determined using PET imaging with [18F]fallypride. Turning performance in the patients with PD as a measure of postural control and the Unified Parkinson's Disease Rating Scale scores pre-exercise and postexercise were determined. Our data showed an exercise-induced increase in [18F]fallypride BP as well as improved postural control in patients with PD who exercised. Changes in DA-D2R BP were not observed in patients with PD who did not exercise. These results suggest that exercise can lead to neuroplasticity in dopaminergic signaling and contribute to improved function that may be task specific (postural control) in early-stage PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636255     DOI: 10.1097/WNR.0b013e328361dc13

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  60 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

2.  Reduced effects of age on dopamine D2 receptor levels in physically active adults.

Authors:  Linh C Dang; Jaime J Castrellon; Scott F Perkins; Nam T Le; Ronald L Cowan; David H Zald; Gregory R Samanez-Larkin
Journal:  Neuroimage       Date:  2017-01-10       Impact factor: 6.556

Review 3.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

4.  Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease.

Authors:  Giselle M Petzinger; Beth E Fisher; Sarah McEwen; Jeff A Beeler; John P Walsh; Michael W Jakowec
Journal:  Lancet Neurol       Date:  2013-07       Impact factor: 44.182

5.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

6.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

Review 7.  From Disease to Health: Physical Therapy Health Promotion Practices for Secondary Prevention in Adult and Pediatric Neurologic Populations.

Authors:  Lori Quinn; Don Morgan
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

8.  Recruitment of the prefrontal cortex and cerebellum in Parkinsonian rats following skilled aerobic exercise.

Authors:  Zhuo Wang; Yumei Guo; Kalisa G Myers; Ryan Heintz; Daniel P Holschneider
Journal:  Neurobiol Dis       Date:  2015-03-03       Impact factor: 5.996

9.  Exercise Improves Cognitive Impairment and Dopamine Metabolism in MPTP-Treated Mice.

Authors:  Aderbal S Aguiar; Samantha C Lopes; Fabrine S M Tristão; Daniel Rial; Gisele de Oliveira; Cláudio da Cunha; Rita Raisman-Vozari; Rui D Prediger
Journal:  Neurotox Res       Date:  2016-01       Impact factor: 3.911

10.  The association between lifestyle factors and Parkinson's disease progression and mortality.

Authors:  Kimberly C Paul; Yu-Hsuan Chuang; I-Fan Shih; Adrienne Keener; Yvette Bordelon; Jeff M Bronstein; Beate Ritz
Journal:  Mov Disord       Date:  2019-01       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.